Data / Form D filings / OPGEN INC
OPGEN INC: Form D filings
OPGEN INC, a biotechnology company in Rockville, MD, filed 21 Form D notices with the SEC between 2009 and 2022. The latest, on October 12, 2022, reports $3.4 million sold of a $3.4 million offering to 1 investor.
Find out what OPGEN INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 9717 KEY WEST AVENUE, SUITE 100, Rockville, MD, 20850
- Phone
- (301) 869-9683
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1293818
The full lists. Form D filings in Maryland: 608 rows, $30.40, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 12, 2022 | New notice | $3,381,338 | $3,381,338 | $0 | 1 | Oct 3, 2022 | sec.gov |
| Feb 24, 2021 | New notice | $25,000,000 | $25,000,000 | $0 | 1 | Feb 11, 2021 | sec.gov |
| Dec 4, 2020 | New notice | $10,000,000 | $9,974,027 | $25,973 | 1 | Nov 25, 2020 | sec.gov |
| Aug 3, 2018 | New notice | $285,512 | $285,512 | $0 | 1 | Jul 30, 2018 | sec.gov |
| Sep 21, 2017 | New notice | $110,000 | $110,000 | $0 | 1 | Sep 13, 2017 | sec.gov |
| Jun 20, 2017 | New notice | $1,500,000 | $500,000 | $1,000,000 | 2 | Jun 6, 2017 | sec.gov |
| May 27, 2016 | New notice | $10,355,005 | $7,227,504 | $3,127,501 | 10 | May 19, 2016 | sec.gov |
| Jul 23, 2015 | New notice | $2,584,090 | $2,584,090 | $0 | 4 | Jul 14, 2015 | sec.gov |
| Feb 23, 2015 | New notice | $1,500,000 | $1,243,999 | $256,001 | 9 | Feb 17, 2015 | sec.gov |
| Jul 17, 2014 | New notice | $1,500,000 | $1,079,917 | $420,083 | 4 | Jul 11, 2014 | sec.gov |
| Apr 4, 2014 | Amendment | $4,000,000 | $3,999,864 | $136 | 29 | Dec 18, 2013 | sec.gov |
| Dec 30, 2013 | New notice | $2,000,000 | $1,999,867 | $133 | 29 | Dec 18, 2013 | sec.gov |
| Mar 14, 2012 | New notice | $17,000,000 | $6,100,000 | $10,900,000 | 28 | Mar 5, 2012 | sec.gov |
| Feb 16, 2012 | Amendment | $3,699,209 | $3,532,442 | $166,767 | 27 | Nov 8, 2011 | sec.gov |
| Dec 9, 2011 | New notice | $2,299,209 | $2,132,442 | $166,767 | 27 | Nov 8, 2011 | sec.gov |
| Feb 22, 2011 | Amendment | $15,722,858 | $11,935,601 | $3,787,257 | 33 | Sep 21, 2010 | sec.gov |
| Oct 6, 2010 | New notice | $15,722,858 | $9,211,141 | $6,511,717 | 15 | Sep 21, 2010 | sec.gov |
| May 10, 2010 | Amendment | $8,186,000 | $4,018,522 | $4,167,478 | 13 | Mar 23, 2010 | sec.gov |
| Mar 31, 2010 | New notice | $8,186,000 | $4,000,000 | $4,186,000 | 11 | Mar 23, 2010 | sec.gov |
| Jan 15, 2010 | Amendment | $4,052,000 | $4,018,336 | $33,664 | 14 | Nov 30, 2009 | sec.gov |
| Dec 11, 2009 | New notice | $4,052,000 | $2,000,000 | $2,052,000 | 12 | Nov 30, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Johannes Donald Bacher | Executive Officer | |
| William E. Rhodes III | Director | |
| Prabhavathi Donald Fernandes | Director | |
| R. Donald Elsey | Director | |
| Mario E. Crovetto | Director | |
| Albert Donald Weber | Executive Officer | |
| Oliver Donald Schacht | Executive Officer, Director |
Other biotechnology companies in Maryland that filed recently
- BlueHealer Inc. $1 · Nov 4, 2026
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
- Uvantis Therapeutics, Inc. $100,000 · Sep 23, 2026
- Gliknik Inc $15 million · Sep 17, 2026
- Georgiamune, Inc. $92.7 million · Aug 17, 2026
Every Form D from the week of Oct 10, 2022 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what OPGEN INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.